These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 13596970)

  • 21. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytological analysis of effects of maleuric acid on Ehrlich ascites tumor cells.
    OKADA TA; ROBERTS E
    Cancer Res; 1960 Sep; 20():1154-9. PubMed ID: 13730569
    [No Abstract]   [Full Text] [Related]  

  • 23. [Research on the effects of anti-coagulants on immunocytolysis of cells of the mouse Ehrlich ascites tumors].
    KAISER E; SPRINGER K
    Wien Klin Wochenschr; 1961 May; 73():314-9. PubMed ID: 13750788
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of lytic agents on plasma membrane of Ehrlich ascites-tumor cells and mouse erythrocytes.
    BENNETT LR; CONNON FE
    J Natl Cancer Inst; 1957 Dec; 19(6):999-1011. PubMed ID: 13502755
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships among purines related to 6-mercaptopurine.
    CLARKE DA; ELION GB; HITCHINGS GH; STOCK CC
    Cancer Res; 1958 May; 18(4):445-56. PubMed ID: 13536996
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG
    Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for quantitative bioassay of Ehrlich ascites-tumors cells.
    PRINCE AM; LITTELL AS; GINSBERG HS
    J Natl Cancer Inst; 1957 Apr; 18(4):487-506. PubMed ID: 13416904
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypersensitivity reaction of highly virulent ascites cancer cells to the antimetabolic effects 2, 4-dinitrophenol].
    WINDISCH F; HEUMANN W; KERNER H
    Z Gesamte Inn Med; 1957 Jan; 12(2):89-90. PubMed ID: 13434225
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytochemical studies on some effects of x-radiation on three ascites tumors.
    CASPERSSON T; KLEIN E; RINGERTZ NR
    Cancer Res; 1958 Aug; 18(7):857-62. PubMed ID: 13573354
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of the effects of viral and bacterial infections on ascites tumors.
    GOLDIE H; JOYNER JW; BROWN CA
    Z Immun exp ther; 1958 Apr; 115(4):284-98. PubMed ID: 13570206
    [No Abstract]   [Full Text] [Related]  

  • 34. The biosynthesis and interconversion of purines and their derivatives.
    MOAT AG; FRIEDMAN H
    Bacteriol Rev; 1960 Sep; 24(3):309-39. PubMed ID: 13771577
    [No Abstract]   [Full Text] [Related]  

  • 35. Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.
    Gay RJ; Amos H
    Biochem J; 1983 Jul; 214(1):133-44. PubMed ID: 6193780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of nucleic acid-related substances by fermentation processes. 33. Accumulation of inosine by a mutant of Brevibacterium ammoniagenes.
    Furuya A; Abe S; Kinoshita S
    Appl Microbiol; 1970 Aug; 20(2):263-70. PubMed ID: 5480102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of 6-thioguanine and 8-azaguanine to non-dividing liver cell cultures.
    Berman JJ; Tong C; Williams GM
    Cell Biol Toxicol; 1985 Jan; 1(2):67-73. PubMed ID: 3917127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
    Sartorelli AC
    Br J Cancer; 1985 Sep; 52(3):293-302. PubMed ID: 3899154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of 6-thioguanine. I. Studies on thioguanine-resistant and-sensitive Ehrlich ascites cells.
    SARTORELLI AC; LEPAGE GA; MOORE EC
    Cancer Res; 1958 Nov; 18(10):1232-9. PubMed ID: 13596970
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.